ELLIOTTS B SOLUTION
CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM SULFATE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE
Approval overview ELLIOTTS B SOLUTION is listed in Drugs@FDA under application 020577 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM SULFATE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE Form and strength INJECTABLE;INTRATHECAL - 0.2MG/ML;0.8MG/ML;0.3MG/ML;0.3MG/ML;1.9MG/ML;7.3MG/ML;0.2MG/ML Sponsor LUKARE MEDICAL LLC Submission history Latest submission status date: 2016-11-29 00:00:00.
Structured Monograph
Clinical summary
Approval overview ELLIOTTS B SOLUTION is listed in Drugs@FDA under application 020577 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM SULFATE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE Form and strength INJECTABLE;INTRATHECAL - 0.2MG/ML;0.8MG/ML;0.3MG/ML;0.3MG/ML;1.9MG/ML;7.3MG/ML;0.2MG/ML Sponsor LUKARE MEDICAL LLC Submission history Latest submission status date: 2016-11-29 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.